EA202192172A1 - METHODS, SYSTEMS AND KITS FOR TREATMENT OF INFLAMMATORY DISEASE - Google Patents

METHODS, SYSTEMS AND KITS FOR TREATMENT OF INFLAMMATORY DISEASE

Info

Publication number
EA202192172A1
EA202192172A1 EA202192172A EA202192172A EA202192172A1 EA 202192172 A1 EA202192172 A1 EA 202192172A1 EA 202192172 A EA202192172 A EA 202192172A EA 202192172 A EA202192172 A EA 202192172A EA 202192172 A1 EA202192172 A1 EA 202192172A1
Authority
EA
Eurasian Patent Office
Prior art keywords
systems
methods
treatment
kits
inflammatory disease
Prior art date
Application number
EA202192172A
Other languages
Russian (ru)
Inventor
Джанин Билсборо
Стефан Р. Тарган
Дермот П. Макговерн
Original Assignee
Сидарс-Синай Медикал Сентер
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сидарс-Синай Медикал Сентер filed Critical Сидарс-Синай Медикал Сентер
Priority claimed from PCT/US2020/017212 external-priority patent/WO2020163715A1/en
Publication of EA202192172A1 publication Critical patent/EA202192172A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

В настоящем документе описаны способы, системы, композиции и наборы, пригодные для диагностики и/или лечения заболевания или состояния у субъекта. Настоящее изобретение относится к способам и системам идентификации и стратификации пациентов, подходящих для лечения модулятором IL18R1, как описано в настоящем документе.Described herein are methods, systems, compositions, and kits useful for diagnosing and/or treating a disease or condition in a subject. The present invention relates to methods and systems for identifying and stratifying patients suitable for treatment with an IL18R1 modulator as described herein.

EA202192172A 2019-03-07 2020-02-07 METHODS, SYSTEMS AND KITS FOR TREATMENT OF INFLAMMATORY DISEASE EA202192172A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962815223P 2019-03-07 2019-03-07
PCT/US2020/017212 WO2020163715A1 (en) 2019-02-08 2020-02-07 Methods, systems, and kits for treating inflammatory disease targeting il18r1

Publications (1)

Publication Number Publication Date
EA202192172A1 true EA202192172A1 (en) 2021-12-17

Family

ID=80631169

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192172A EA202192172A1 (en) 2019-03-07 2020-02-07 METHODS, SYSTEMS AND KITS FOR TREATMENT OF INFLAMMATORY DISEASE

Country Status (1)

Country Link
EA (1) EA202192172A1 (en)

Similar Documents

Publication Publication Date Title
EA201590630A1 (en) METHODS OF TREATMENT AND DIAGNOSTICS ASSOCIATED WITH LYZYLOXIDE-LIKE PROTEIN 2 (LOXL2)
EA201990778A1 (en) ANTI-IL-33 ANTIBODIES AND THEIR APPLICATION
EA201890453A1 (en) ANTI-ANGPTL8 ANTIBODIES AND THEIR APPLICATION
BR112018016226A2 (en) human monoclonal anti-lamella antibody (anti-lam) antibody, human monoclonal anti-lam antibody, human monoclonal anti-pim6 / lam antibody, kit for detecting at least one lam epitope, method for diagnosing an active tuberculosis infection in an individual, and method to treat a tuberculosis infection in an individual
EA201591754A1 (en) HUMAN ANTIBODIES TO NA1.7
EA201391587A1 (en) COMBINED THERAPY BASED ON HSP90
EA201270803A1 (en) TIOACATETIC COMPOUNDS, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR APPLICATION
MX2020001193A (en) Methods for determining dpp3 and therapeutic methods.
CY1120877T1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ABDOMINAL
EA201792641A1 (en) IGFBP3 / TMEM219 AXIS INHIBITOR AND DIABETES
EA201792669A1 (en) IGFBP3 AND ITS APPLICATION
EA202191666A1 (en) ANTIBODIES TO IL-27 AND THEIR USE
MX2019003569A (en) Methods for treating cancer with bavituximab based on levels of î²2-glycoprotein 1, and assays therefor.
NZ729773A (en) Biomarkers for disease progression in melanoma
EA201891664A1 (en) COMPOSITIONS / COMPOSITIONS CONTAINING BTK INHIBITOR
EA201891527A1 (en) COMPOSITIONS AND METHODS OF DETECTION AND TREATMENT OF CANCER ETHESIS
EA202092748A1 (en) APOL1 EXPRESSION MODULATORS
EA202192288A1 (en) COMPOUNDS BASED ON NEUREGULIN-4 AND METHODS FOR THEIR APPLICATION
MX2021009247A (en) Methods, systems, and kits for treating inflammatory disease targeting il18r1.
EA201890347A1 (en) ANTIBODIES AND RESEARCH FOR DETECTION CD37
EA202191342A1 (en) IRF5 EXPRESSION MODULATORS
CL2021002169A1 (en) Methods to obtain induced smooth muscle cells
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE
MX2021007951A (en) Multiplexed assay and methods of use thereof.
EA202192172A1 (en) METHODS, SYSTEMS AND KITS FOR TREATMENT OF INFLAMMATORY DISEASE